The European cell sheet-based gene therapy market is experiencing significant growth. This sector is driven by an increasing demand for innovative therapeutic solutions to address a wide range of genetic conditions. Successful clinical trials and regulatory authorizations are fueling market progress. A key factor contributing to this trend is the p